Early Conversion from Twice Daily Tacrolimus to the Once Daily Extended Formulation in Renal Transplant Patients before Hospital Discharge

被引：0
|
作者：
Jannot, M. [1 ]
Faist, F.
Maillard, N. [1 ]
Masson, I. [1 ]
Alamartine, E. [1 ]
Mariat, C. [1 ]
机构：
[1] Univ Hosp, Renal Transplantat Dpt, St Etienne, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
586
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [41] Conversion from Twice Daily Immediate Release Tacrolimus to Once Daily Extended Release Tacrolimus (LCP-Tacro) in High Risk Kidney Transplant Recipients.
    Benincasa, M.
    Colomy, V.
    Sifontis, N.
    Rao, S.
    Lau, K.
    Karhadkar, S.
    Di Carlo, A.
    Diamond, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 806 - 806
  • [42] The Impact of Conversion from Immediate Release Twice-Daily Tacrolimus (Prograf®) to Once-Daily Extended Release Tacrolimus (Envarsus®) in Liver Transplant Recipients.
    Del Gaudio, M.
    Cescon, M.
    Ravaioli, M.
    Bertuzzo, V.
    Zanfi, C.
    Serenari, M.
    Maroni, L.
    Morelli, C.
    Pinna, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 839 - 839
  • [43] RENAL FUNCTION AND SAFETY IN STABLE KIDNEY RECIPIENTS CONVERTED FROM TACROLIMUS TWICE DAILY TO A ONCE-DAILY FORMULATION
    Kraemer, B.
    Morales, J.
    Lauzurica, R.
    van Hooff, J. P.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 8 - 8
  • [44] INTRAPATIENT VARIABILITY IN PATIENTS SWITCHED FROM TWICE DAILY TO ONCE DAILY TACROLIMUS
    Mechref, Zeina
    Chelala, Dania
    Hadi, Al Issam
    Azar, Hiba
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [45] Renal Function and Safety in Stable Kidney Recipients Converted from Tacrolimus Twice Daily to a Once-Daily Formulation
    Morales, J.
    Lauzurica, R.
    van Hooff, J. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 512 - 512
  • [46] Conversion from twice-daily to once-daily tacrolimus formulation in pediatric liver transplant recipients - a long-term prospective study
    Quintero, Jesus
    Juamperez, Javier
    Ortega, Juan
    Molino, Jose A.
    Castells, Lluis
    Bilbao, Itxarone
    Rodrigo, Carlos
    Charco, Ramon
    TRANSPLANT INTERNATIONAL, 2018, 31 (01) : 38 - 44
  • [47] Conversion From Twice-Daily to Once-Daily Tacrolimus Formulation Does Not Reduce Intra-Patient Variability in Tacrolimus Exposure
    Shuker, N.
    van Gelder, T.
    Cadogan, M.
    Weimar, W.
    Hesselink, D. A.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 711 - 711
  • [48] Conversion From the Twice-Daily to the Once-Daily Tacrolimus Formulation Does Not Reduce Intra-Patient Variability in Tacrolimus Exposure
    Shuker, N.
    van Gelder, T.
    Cadogan, M.
    Weimar, W.
    Hesselink, D.
    TRANSPLANTATION, 2014, 98 : 460 - 460
  • [49] CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS FORMULATION DOES NOT REDUCE INTRA-PATIENT VARIABILITY IN TACROLIMUS EXPOSURE
    Shuker, Nauras
    Gelder, Teunvan
    Monique, Cadogan
    Weimar, Willem
    Hesselink, Dennis A.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 240 - 240
  • [50] Comparison of Extended-Release, Once Daily Tacrolimus and Standard Twice Daily Tacrolimus in De Novo Liver Transplant Recipients
    Lim, T. Y.
    Shah, N.
    Shah, A.
    Mahgoub, S.
    Considine, A.
    Joshi, D.
    Sanchez-Fueyo, A.
    Suddle, A.
    Heaton, N.
    O'Grady, J.
    Heneghan, M. A.
    Agarwal, K.
    Aluvihare, V.
    TRANSPLANTATION, 2017, 101 (05) : 120 - 120
12345